StonvexLoading…
StonvexStonvexStonvexCore line items from ZTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.26B | $9.47B | $7.08B | $4.68B |
Operating Income | $758.00M | $3.36B | $2.60B | $1.71B |
Net Income | $601.00M | $2.67B | $2.07B | $1.35B |
EPS (Diluted) | $1.42 | $6.02 | $4.65 | $3.02 |
Total Assets | $15.15B | $15.49B | $15.16B | $14.48B |
Total Liabilities | $11.92B | $12.07B | $9.76B | $9.50B |
Cash & Equivalents | $1.94B | $2.45B | $2.08B | $1.44B |
Free Cash Flow OCF − CapEx | $291.00M | $2.28B | $1.55B | $746.00M |
Shares Outstanding | 420.35M | 424.93M | 441.46M | 443.95M |